Your acute migraine doesn’t have to keep you in the dark. Consider the EMERGE Study today.
Can I Participate?
You may be able to participate in the Emerge Study if:
The investigational medication is taken as powder that is administered into your nose.
You will receive all study-related care at no cost. Health insurance is not needed.
Migraine is a common, but incapacitating, neurological disease that affects approximately 39 million people in the United States alone.
Migraine is the
most prevalent illness in the world
Migraine typically involves a severe throbbing recurring pain, usually on one side of the head.
Migraine is most common between the ages of 25 and 55.
of migraine sufferers have a family history of migraine.
Attacks are often accompanied by one of more of the following: nausea, vomiting, extreme sensitivity to sound, light, touch and smell, and tingling or numbness of the extremities of face.
Attacks usually last between 4 and 72 hours.
There is still so much research that needs to be done so better treatments can come to the market. This is where the EMERGE Study comes in.